Narcolepsy screening: Difference between revisions
Homa Najafi (talk | contribs) (Created page with "__NOTOC__ {{Narcolepsy}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the [guidel...") |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{Narcolepsy}} | {{Narcolepsy}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{MWH}} | ||
==Overview== | ==Overview== | ||
| Line 33: | Line 33: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Neurology]] | |||
Latest revision as of 14:42, 31 July 2020
|
Narcolepsy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Narcolepsy screening On the Web |
|
American Roentgen Ray Society Images of Narcolepsy screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Muhammad Waleed Haider, M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]